BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 34636872)

  • 1. Vaccine-Induced SARS-CoV-2 Antibodies in Inflammatory Diseases.
    Abbasi J
    JAMA; 2021 Oct; 326(14):1365. PubMed ID: 34636872
    [No Abstract]   [Full Text] [Related]  

  • 2. Most Fully Vaccinated Patients With Cancer Have SARS-CoV-2 Antibodies.
    Slomski A
    JAMA; 2021 Sep; 326(9):800. PubMed ID: 34547092
    [No Abstract]   [Full Text] [Related]  

  • 3. Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine.
    Krammer F; Srivastava K; Alshammary H; Amoako AA; Awawda MH; Beach KF; Bermúdez-González MC; Bielak DA; Carreño JM; Chernet RL; Eaker LQ; Ferreri ED; Floda DL; Gleason CR; Hamburger JZ; Jiang K; Kleiner G; Jurczyszak D; Matthews JC; Mendez WA; Nabeel I; Mulder LCF; Raskin AJ; Russo KT; Salimbangon AT; Saksena M; Shin AS; Singh G; Sominsky LA; Stadlbauer D; Wajnberg A; Simon V
    N Engl J Med; 2021 Apr; 384(14):1372-1374. PubMed ID: 33691060
    [No Abstract]   [Full Text] [Related]  

  • 4. Serosurvey in BNT162b2 vaccine-elicited neutralizing antibodies against authentic B.1, B.1.1.7, B.1.351, B.1.525 and P.1 SARS-CoV-2 variants.
    Zani A; Caccuri F; Messali S; Bonfanti C; Caruso A
    Emerg Microbes Infect; 2021 Dec; 10(1):1241-1243. PubMed ID: 34092181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 Antibody Response in Persons with Past Natural Infection.
    Anichini G; Terrosi C; Gandolfo C; Gori Savellini G; Fabrizi S; Miceli GB; Cusi MG
    N Engl J Med; 2021 Jul; 385(1):90-92. PubMed ID: 33852796
    [No Abstract]   [Full Text] [Related]  

  • 6. Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients.
    Kamar N; Abravanel F; Marion O; Couat C; Izopet J; Del Bello A
    N Engl J Med; 2021 Aug; 385(7):661-662. PubMed ID: 34161700
    [No Abstract]   [Full Text] [Related]  

  • 7. Study Suggests Lasting Immunity After COVID-19, With a Big Boost From Vaccination.
    Abbasi J
    JAMA; 2021 Aug; 326(5):376-377. PubMed ID: 34259836
    [No Abstract]   [Full Text] [Related]  

  • 8. SARS-CoV-2-specific T cell immunity to structural proteins in inactivated COVID-19 vaccine recipients.
    Deng Y; Li Y; Yang R; Tan W
    Cell Mol Immunol; 2021 Aug; 18(8):2040-2041. PubMed ID: 34267334
    [No Abstract]   [Full Text] [Related]  

  • 9. Safety and Immunogenicity of a Third Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series.
    Werbel WA; Boyarsky BJ; Ou MT; Massie AB; Tobian AAR; Garonzik-Wang JM; Segev DL
    Ann Intern Med; 2021 Sep; 174(9):1330-1332. PubMed ID: 34125572
    [No Abstract]   [Full Text] [Related]  

  • 10. Decreased Antibody Responses to Ad26.COV2.S Relative to SARS-CoV-2 mRNA Vaccines in Patients With Inflammatory Bowel Disease.
    Pozdnyakova V; Botwin GJ; Sobhani K; Prostko J; Braun J; Mcgovern DPB; Melmed GY; Appel K; Banty A; Feldman E; Ha C; Kumar R; Lee S; Rabizadeh S; Stein T; Syal G; Targan S; Vasiliauskas E; Ziring D; Debbas P; Hampton M; Mengesha E; Stewart JL; Frias EC; Cheng S; Ebinger J; Figueiredo JC; Boland B; Charabaty A; Chiorean M; Cohen E; Flynn A; Valentine J; Fudman D; Horizon A; Hou J; Hwang C; Lazarev M; Lum D; Fausel R; Reddy S; Mattar M; Metwally M; Ostrov A; Parekh N; Raffals L; Sheibani S; Siegel C; Wolf D; Younes Z
    Gastroenterology; 2021 Dec; 161(6):2041-2043.e1. PubMed ID: 34391771
    [No Abstract]   [Full Text] [Related]  

  • 11. Patients with Solid Tumors Seroconvert after SARS-CoV-2 mRNA Vaccine.
    Cancer Discov; 2021 Sep; 11(9):2122. PubMed ID: 34272229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterologous ChAdOx1 nCoV-19 and mRNA-1273 Vaccination.
    Normark J; Vikström L; Gwon YD; Persson IL; Edin A; Björsell T; Dernstedt A; Christ W; Tevell S; Evander M; Klingström J; Ahlm C; Forsell M
    N Engl J Med; 2021 Sep; 385(11):1049-1051. PubMed ID: 34260850
    [No Abstract]   [Full Text] [Related]  

  • 13. Safety and Immunogenicity of Anti-SARS-CoV-2 Messenger RNA Vaccines in Recipients of Solid Organ Transplants.
    Marion O; Del Bello A; Abravanel F; Couat C; Faguer S; Esposito L; Hebral AL; Izopet J; Kamar N
    Ann Intern Med; 2021 Sep; 174(9):1336-1338. PubMed ID: 34029487
    [No Abstract]   [Full Text] [Related]  

  • 14. Antibody Kinetics and Durability in SARS-CoV-2 mRNA Vaccinated Solid Organ Transplant Recipients.
    Boyarsky BJ; Chiang TP; Teles AT; Greenberg RS; Krach MR; Ou MT; Massie AB; Tobian AAR; Garonzik-Wang JM; Segev DL; Werbel AWA
    Transplantation; 2021 Oct; 105(10):e137-e138. PubMed ID: 34241987
    [No Abstract]   [Full Text] [Related]  

  • 15. Serological response in health care workers after a single dose of SARS-CoV-2 vaccine using six automated SARS-CoV-2 antibody assays.
    Cuykx M; Mortelé O; Jansens H; Schouwers S; Meskal A; Hoffbauer I; Peeters B
    Diagn Microbiol Infect Dis; 2021 Oct; 101(2):115486. PubMed ID: 34332306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A French cohort for assessing COVID-19 vaccine responses in specific populations.
    Loubet P; Wittkop L; Tartour E; Parfait B; Barrou B; Blay JY; Hourmant M; Lachâtre M; Laplaud DA; Laville M; Laviolle B; Lelievre JD; Morel J; Nguyen S; Spano JP; Terrier B; Thiebaut A; Viallard JF; Vrtovsnik F; de Lamballerie X; Launay O
    Nat Med; 2021 Aug; 27(8):1319-1321. PubMed ID: 34253930
    [No Abstract]   [Full Text] [Related]  

  • 17. No Correlation between Anti-PF4 and Anti-SARS-CoV-2 Antibodies after ChAdOx1 nCoV-19 Vaccination.
    Uzun G; Althaus K; Bakchoul T
    N Engl J Med; 2021 Sep; 385(14):1334-1336. PubMed ID: 34432977
    [No Abstract]   [Full Text] [Related]  

  • 18. Expected Viscosity After COVID-19 Vaccination, Hyperviscosity and Previous COVID-19.
    Joob B; Wiwanitkit V
    Clin Appl Thromb Hemost; 2021; 27():10760296211020833. PubMed ID: 34142570
    [No Abstract]   [Full Text] [Related]  

  • 19. Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial.
    Xia S; Zhang Y; Wang Y; Wang H; Yang Y; Gao GF; Tan W; Wu G; Xu M; Lou Z; Huang W; Xu W; Huang B; Wang H; Wang W; Zhang W; Li N; Xie Z; Ding L; You W; Zhao Y; Yang X; Liu Y; Wang Q; Huang L; Yang Y; Xu G; Luo B; Wang W; Liu P; Guo W; Yang X
    Lancet Infect Dis; 2021 Jan; 21(1):39-51. PubMed ID: 33069281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody Responses after a Single Dose of SARS-CoV-2 mRNA Vaccine.
    Bradley T; Grundberg E; Selvarangan R; LeMaster C; Fraley E; Banerjee D; Belden B; Louiselle D; Nolte N; Biswell R; Pastinen T; Myers A; Schuster J
    N Engl J Med; 2021 May; 384(20):1959-1961. PubMed ID: 33755375
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.